Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer

We tried to establish models that predict systemic recurrence in breast cancer by selecting marker clones with DNA copy number alterations (CNAs) using an array comparative genomic hybridization (CGH). Array CGH containing 4,044 human bacterial artificial chromosome clones was used to assess CNAs in 62 primary breast cancer tissues from 31 patients with systemic recurrence within 5 years after surgery and clinicopathologically well matched 31 patients who had no evidence of disease for at least 5years. Fourteen significant clones (11 clones showing gain and 3 showing loss) were identified by systemic recurrence‐free survival (SRFS) analysis and 23 significant clones (17 clones showing gain and 6 showing loss) identified by χ2 test and FDR test were selected as predictive markers of systemic breast cancer recurrence. The significant CNAs were found in the chromosomal regions of 5p15.33, 11q13.3, 15q26.3, 17q25.3, 18q23 and 21q22.3 with gain and 9p12, 11q24.1 and 14q32.33 with loss. We devised 2 prediction models for the systemic recurrence of breast cancer based on the 14 clones and the 23 clones, respectively. The survivals of the patients were significantly separated according to the scores from each model at the optimal cut off values in SRFS and overall survival analysis. We found candidate clones and genes of which CNAs were significantly associated with systemic recurrence of breast cancer. The devised prediction models with these clones were effective at differentiating the recurrence and nonrecurrence. © 2008 Wiley‐Liss, Inc.

[1]  P. O’Connell,et al.  Advances in Brief Loss of Heterozygosity Events Impeding Breast Cancer Metastasis Contain the MTA 1 Gene 1 , 2001 .

[2]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Nederlof,et al.  Array-CGH and breast cancer , 2006, Breast Cancer Research.

[4]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[5]  P. Banerjee,et al.  Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha. , 2006, Biochemical and biophysical research communications.

[6]  D. Brenner,et al.  Immortal Activated Human Hepatic Stellate Cells Generated by Ectopic Telomerase Expression , 2002, Laboratory Investigation.

[7]  R. Gelber,et al.  Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  J W Gray,et al.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Wang,et al.  High Expression of Human Telomerase Reverse Transcriptase in High-Grade Intraepithelial Neoplasia and Carcinoma of Uterine Cervix and Its Correlation With Human Papillomavirus Infection , 2007, Reproductive Sciences.

[10]  Barbara J. Trask,et al.  Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes , 2004, Cancer Research.

[11]  S. Hilsenbeck,et al.  Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. , 1995, The American journal of pathology.

[12]  Harold C. Sox,et al.  National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making , 1988 .

[13]  N. Haites,et al.  Genomic changes identified by comparative genomic hybridisation in docetaxel-resistant breast cancer cell lines. , 2005, European journal of cancer.

[14]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[15]  Li Mao,et al.  hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  Robert J. Mayer,et al.  National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. , 2001, Journal of the National Cancer Institute.

[17]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. V. van Diest,et al.  In lymph node‐negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor , 2003, The Journal of pathology.

[19]  P. Lichter,et al.  Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. , 2005, Cancer research.

[20]  Wei Wang,et al.  A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. , 2004, Cancer cell.

[21]  C. Luebbert,et al.  Comparative Genomic Hybridization: insights from an empirical , 2005 .

[22]  A. Okamoto,et al.  A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. , 2001, Biochemical and biophysical research communications.

[23]  C. Cooper,et al.  Applications of microarray technology in breast cancer research , 2001, Breast Cancer Research.

[24]  I. Ellis,et al.  The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.

[25]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[26]  Lajos Pusztai,et al.  Gene expression profiling of breast cancer , 2009, Breast Cancer Research.

[27]  J. Dimmock,et al.  Expression of methionine aminopeptidase 2, N-myristoyltransferase, and N-myristoyltransferase inhibitor protein 71 in HT29. , 2004, Biochemical and biophysical research communications.

[28]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Loddenkemper,et al.  Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. , 2006, Oncology reports.

[30]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[31]  Ash A. Alizadeh,et al.  Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.

[32]  Joel Greshock,et al.  High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization , 2005, Breast Cancer Research.

[33]  L. Qin,et al.  Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma. , 2003, Hepato-gastroenterology.

[34]  S. Tavaré,et al.  High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer , 2007, Genome Biology.

[35]  A. Nobel,et al.  Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .

[36]  K. Yoo,et al.  Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996–2004 , 2006, Breast Cancer Research and Treatment.

[37]  Jorma Isola,et al.  Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. , 2003, Cancer research.

[38]  Wonshik Han,et al.  Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer , 2006, BMC Cancer.

[39]  M. West,et al.  Genomic prediction of locoregional recurrence after mastectomy in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Ian M. Wilson,et al.  Array CGH technologies and their applications to cancer genomes , 2005, Chromosome Research.

[41]  Jenny C. Chang,et al.  Survival of patients with metastatic breast carcinoma , 2003, Cancer.

[42]  Jian-jun Zhang,et al.  Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth in vitro. , 2006, World journal of gastroenterology.

[43]  Y. Wang,et al.  High-resolution array-CGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer , 2007 .

[44]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[45]  S. Dudoit,et al.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.

[46]  K. Miller,et al.  Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer , 2005, International journal of cancer.

[47]  Howard Y. Chang,et al.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Karen A Gelmon,et al.  Population-based validation of the prognostic model ADJUVANT! for early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  D. Albertson.  Profiling Breast Cancer by Array CGH , 2003, Breast Cancer Research and Treatment.

[50]  A. Nobel,et al.  The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.